Wechelpharma SRL
Wechelpharma reported total assets of €2.48m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Mar 2026).
The score of Wechelpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +58 % Total assets +10 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wechelpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Mar 2026
- Year ended 31 Dec 2024filed on 26 Feb 2025
- Year ended 31 Dec 2023filed on 04 Mar 2024
- Year ended 31 Dec 2022filed on 22 Jun 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
Wechelpharma's financial analysis
- Solvency74.6%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wechelpharma
Wechelpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0885.230.908
- VAT number
- BE0885230908
- Peppol
- Registered · 0208:0885230908 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Nov 2006
- Registered office
- 2275 Lille
- Latest accounts
- 2025 · filed on 23 Mar 2026
- Activity
- Activities of holding companies (NACE 64210)
Wechelpharma (SRL) has been based in Lille since 2006, active in: activities of holding companies. For 2025, it reports a net profit of 653,281 € and equity of €1.85m; its revenue is not published. Its solvency stands at 74.6%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Wechelpharma
Companies in the same business, of comparable size and area, outside its group.
- Fraverwest Activities of holding companies Staden · balance sheet €2.48m
- Cemlon Activities of holding companies Kortrijk · balance sheet €2.48m
- Urraco Landbouw Fonds Activities of holding companies Berlaar · balance sheet €2.48m
- Evafc Activities of holding companies Zwevegem · balance sheet €2.48m
- Pircalco Activities of holding companies Sint-Niklaas · balance sheet €2.49m
- Zapfloor Invest Activities of holding companies Leuven · balance sheet €2.47m
- Verace Activities of holding companies Affligem · balance sheet €2.49m
- Meditrine Activities of holding companies Etterbeek · balance sheet €2.49m
Frequently asked questions about Wechelpharma
What is the revenue of Wechelpharma?
Wechelpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wechelpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0885230908 for Wechelpharma, if the company is VAT-registered. Its company number (CBE) is 0885.230.908.
Where is the registered office of Wechelpharma?
According to the CBE register, the registered office of Wechelpharma is in 2275 Lille.
What is the equity of Wechelpharma?
At the close of the 2025 financial year, the equity of Wechelpharma amounts to 1,850,611 €, a solvency of 74.6% of total assets.
Who manages Wechelpharma?
The register lists 2 active mandates at Wechelpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Wechelpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →